Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Elias Sarkis"'
Autor:
Adrienne E. Shapiro, Elias Sarkis, Jude Acloque, Almena Free, Yaneicy Gonzalez-Rojas, Rubaba Hussain, Erick Juarez, Jaynier Moya, Naval Parikh, David Inman, Deborah Cebrik, Ahmed Nader, Nadia Noormohamed, Qianwen Wang, Andrew Skingsley, Daren Austin, Amanda Peppercorn, Maria L. Agostini, Sergio Parra, Sophia Chow, Erik Mogalian, Phillip S. Pang, David K. Hong, Jennifer E. Sager, Wendy W. Yeh, Elizabeth L. Alexander, Leah A. Gaffney, Anita Kohli
BackgroundConvenient administration of coronavirus disease 2019 (COVID-19) treatment in community settings is desirable. Sotrovimab is a pan-sarbecovirus dual-action monoclonal antibody formulated for intravenous (IV) or intramuscular (IM) administra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6eb08d2911a70bce8dc0f30cdc3cae2d
https://doi.org/10.1101/2023.03.21.23287410
https://doi.org/10.1101/2023.03.21.23287410
Autor:
Anil, Gupta, Yaneicy, Gonzalez-Rojas, Erick, Juarez, Manuel, Crespo Casal, Jaynier, Moya, Diego, Rodrigues Falci, Elias, Sarkis, Joel, Solis, Hanzhe, Zheng, Nicola, Scott, Andrea L, Cathcart, Sergio, Parra, Jennifer E, Sager, Daren, Austin, Amanda, Peppercorn, Elizabeth, Alexander, Wendy W, Yeh, Cynthia, Brinson, Melissa, Aldinger, Adrienne E, Shapiro, Lawrence, Sher
Publikováno v:
JAMA
IMPORTANCE: Older patients and those with comorbidities who are infected with SARS-CoV-2 may be at increased risk of hospitalization and death. Sotrovimab is a neutralizing antibody for the treatment of high-risk patients to prevent COVID-19 progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3072af5f0c357da130288d9bee64ef34
https://pubmed.ncbi.nlm.nih.gov/35285853
https://pubmed.ncbi.nlm.nih.gov/35285853
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: In two studies of adult attention-deficit/hyperactivity disorder (ADHD), SHP465 mixed amphetamine salts (MAS) extended-release significantly reduced ADHD-Rating Scale, 4th Edition total score (ADHD-RS-IV-TS) versus placebo (PBO). This rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99adf38e4a06321a8826502bb290b6d6
http://europepmc.org/articles/PMC7475095
http://europepmc.org/articles/PMC7475095
Autor:
Adrienne E. Shapiro, Elias Sarkis, Jude Acloque, Almena Free, Yaneicy Gonazalez-Rojas, Rubaba Hussain, Erick Juarez, Jaynier Moya, Naval Parikh, David Inman, Deborah Cebrik, Ahmed Nadeer, Nadia Noormohamed, Qianwen Wang, Andrew Skingsley, Daren Austin, Amanda Peppercorn, Sergio Parra, Sophia Chow, Erik Mogalian, Phillip S. Pang, David K. Hong, Jennifer E. Sager, Wendy W. Yeh, Elizabeth Alexander, Leah A. Gaffney, Anita Kohli
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3752de56eceb4b7a72aa696a1c003010
https://doi.org/10.2139/ssrn.4111060
https://doi.org/10.2139/ssrn.4111060
Autor:
Anil Gupta, Manuel Crespo, Daren Austin, Adrienne E. Shapiro, Erick Juarez, Jennifer Sager, Joel Solis, Elizabeth Alexander, Amanda Peppercorn, Yaneicy Gonzalez-Rojas, Cynthia Brinson, Hanzhe Zheng, Nicola Scott, Elias Sarkis, Melissa Aldinger, Andrea L. Cathcart, Jaynier Moya, Diego R. Falci, Sergio Parra, Wendy W. Yeh
ImportanceOlder patients and those with underlying comorbidities infected with SARS-CoV-2 may be at increased risk of hospitalization and death from COVID-19. Sotrovimab is a neutralizing antibody designed for treatment of high-risk patients to preve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a11230f5e0001f5702dcccf0ad2543a0
https://doi.org/10.1101/2021.11.03.21265533
https://doi.org/10.1101/2021.11.03.21265533
Autor:
Anil, Gupta, Yaneicy, Gonzalez-Rojas, Erick, Juarez, Manuel, Crespo Casal, Jaynier, Moya, Diego R, Falci, Elias, Sarkis, Joel, Solis, Hanzhe, Zheng, Nicola, Scott, Andrea L, Cathcart, Christy M, Hebner, Jennifer, Sager, Erik, Mogalian, Craig, Tipple, Amanda, Peppercorn, Elizabeth, Alexander, Phillip S, Pang, Almena, Free, Cynthia, Brinson, Melissa, Aldinger, Adrienne E, Shapiro, Luis, Zepeda
Publikováno v:
The New England journal of medicine. 385(21)
Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization or death in older patients and those with underlying conditions. Sotrovimab is a pan-sarbecovirus monoclonal antibody that was designed to prevent progression of Covid-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5f445ae6fb12ebf06154da972781a2
https://pubmed.ncbi.nlm.nih.gov/35294998
https://pubmed.ncbi.nlm.nih.gov/35294998
Autor:
Anil Gupta, Erik Mogalian, Yaneicy Gonzalez-Rojas, Manuel Crespo Casal, Melissa Aldinger, Elizabeth Alexander, Elias Sarkis, Amanda Peppercorn, Hanzhe Zheng, Christy M. Hebner, Joel Solis, Nicola Scott, Craig Tipple, Andrea L. Cathcart, Diego R. Falci, Adrienne E. Shapiro, Almena Free, Jennifer Sager, Jaynier Moya, Phillip S. Pang, Cynthia Brinson, Erick Juarez
BackgroundCoronavirus disease 2019 (Covid-19) disproportionately results in hospitalization and death in older patients and those with underlying comorbidities. Sotrovimab is a pan-sarbecovirus monoclonal antibody designed to treat such high-risk pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdcbc8747e377498858eb2160f81d3a4
https://doi.org/10.1101/2021.05.27.21257096
https://doi.org/10.1101/2021.05.27.21257096
Autor:
Joan Gu, Manisha Madhoo, Matthew Dauphin, Olga Brawman-Mintzer, Roger S. McIntyre, Rajnish Mago, Dan V. Iosifescu, Brooke Geibel, Elias Sarkis, Cynthia Richards, Richard H. Weisler
Publikováno v:
Journal of Clinical Psychopharmacology
Supplemental digital content is available in the text.
Purpose/Background Psychostimulant augmentation is considered a potential treatment strategy for individuals with major depressive disorder who do not adequately respond to antidepressant mo
Purpose/Background Psychostimulant augmentation is considered a potential treatment strategy for individuals with major depressive disorder who do not adequately respond to antidepressant mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f40348d4095c16035829e998aeea495
http://europepmc.org/articles/PMC6039401
http://europepmc.org/articles/PMC6039401
Autor:
Matthew Dauphin, Rajnish Mago, James M. Reynolds, Elias Sarkis, Cynthia Richards, Brooke Geibel, Dan V. Iosifescu
Publikováno v:
Journal of Psychopharmacology (Oxford, England)
Background: This randomized, double-blind, placebo-controlled study evaluated dose-response relationships of lisdexamfetamine dimesylate when used as augmentation for major depressive disorder in individuals exhibiting inadequate responses to antidep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d845c8f46206f9edbcd64be5befc56cd
http://europepmc.org/articles/PMC5606302
http://europepmc.org/articles/PMC5606302
Autor:
Elias Sarkis
Publikováno v:
Postgraduate Medicine. 126:25-30
Although generally considered a childhood disorder, attention-deficit/hyperactivity disorder (ADHD) can persist into adulthood and impede achievement in the workplace. Core ADHD symptoms of inattention, hyperactivity, and impulsivity can be associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea41ba403c5e3637e7a7adb1b145c64
https://doi.org/10.3810/pgm.2014.09.2797
https://doi.org/10.3810/pgm.2014.09.2797